New therapies for unresectable or metastatic cutaneous eyelid and orbital melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New therapies for unresectable or metastatic cutaneous eyelid and orbital melanoma

Published:2024-05-26 Issue: Volume: Page:1-7
ISSN:0167-6830
Container-title:Orbit
language:en
Short-container-title:Orbit

Author:

Wladis Edward J.¹²^ORCID,Rothschild Michael I.¹^ORCID,Bohnak Carisa E.¹,Adam Alejandro P.¹³

Affiliation:

1. Department of Ophthalmology, Lions Eye Institute, Albany Medical College, Albany, New York, USA

2. Department of Otolaryngology, Albany Medical College, Albany, New York, USA

3. Molecular and Cellular Physiology, Albany Medical College, Albany, New York, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/01676830.2024.2351514

Reference42 articles.

1. Primary orbital melanoma: a case series and literature review

2. Melanoma of the eyelid and periocular skin: Histopathologic classification and molecular pathology

3. Recent advances in molecular targeted therapy for unresectable and metastatic BRAF-mutated melanoma

4. Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

5. Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP